Yourgene Health (YGEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 14.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 15.25
  • 52 Week Low: 10.75
  • Currency: UK Pounds
  • Shares Issued: 599.00m
  • Volume: 0
  • Market Cap: 88.35m

YGEN Overview

Yourgene Health is in the pharma and biotech sector and is currently trading at 14.75p per share. In the last year Yourgene Health 's share price has ranged from 10.75p to 15.25p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart (17-01-2020)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -53.8% -3.8%
ROCE 362.4%  
Latest F'cast
P/E 14.7 n/a
PEG n/a n/a
Pr/Revenue 9.9 5.2
Pr/Book 8.3  
Latest F'cast
Revenue 44.4% 91.4%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

YGEN Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-15 0.13 (7.45) (5.00)p n/a n/a n/a n/a 0.0%
31-Mar-16 2.45 (12.12) (6.00)p n/a n/a n/a n/a 0.0%
31-Mar-17 3.08 (7.85) 3.00p 3.9 n/a n/a n/a 0.0%
31-Mar-18 6.15 (9.54) (3.00)p n/a n/a n/a n/a 0.0%
31-Mar-19 8.88 3.39 1.00p 12.5 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

YGEN Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-20 16.99 (0.65) (0.09)p n/a n/a n/a n/a 0.0%
31-Mar-21 20.90 0.78 0.10p 144.6 n/a n/a n/a 0.0%
31-Mar-22 24.73 2.31 0.30p 48.4 0.2 +198% n/a 0.0%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

YGEN Company Announcements

Half-year Report 02-Dec-2019 07:00 RNS
Notice of Results 12-Nov-2019 10:12 RNS
Director/PDMR Shareholding 01-Nov-2019 07:00 RNS

Latest YGEN Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

YGEN Market Data

Currency UK Pounds
Share Price 14.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 15.25
52 Week Low 10.75
Volume 0
Shares Issued 599.00m
Market Cap 88.35m

YGEN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
25.41% below the market average25.41% below the market average25.41% below the market average25.41% below the market average25.41% below the market average
37.93% above the sector average37.93% above the sector average37.93% above the sector average37.93% above the sector average37.93% above the sector average
Price Trend
89.11% above the market average89.11% above the market average89.11% above the market average89.11% above the market average89.11% above the market average
86.21% above the sector average86.21% above the sector average86.21% above the sector average86.21% above the sector average86.21% above the sector average
Income Not Available
Growth
56.54% above the market average56.54% above the market average56.54% above the market average56.54% above the market average56.54% above the market average
63.16% above the sector average63.16% above the sector average63.16% above the sector average63.16% above the sector average63.16% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

YGEN Dividends

No dividends found

Trades for --2020

Time Volume / Share Price
0 @ 0.000p

YGEN Key Personnel

CFO Barry Kenneth Hextall
CEO Lyn Rees
COO Keng Hsu

Top of Page